AMPHETAMINE (AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE (COMPLEXED WITH SODIUM POLYSTYRENE SULFONATE)) — all Canadian products
5 DINs
5 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is AMPHETAMINE (AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE (COMPLEXED WITH SODIUM POLYSTYRENE SULFONATE)), with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02559781 | DYANAVEL XR | KYE PHARMACEUTICALS INC. | Suspension (Extended-Release) | Oral | AMPHETAMINE (AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE (COMPLEXED WITH SODIUM POLYSTYRENE SULFONATE)) 2.5 MG | Approved | |
| 02559803 | DYANAVEL XR | KYE PHARMACEUTICALS INC. | Tablet (Extended-Release) | Oral | AMPHETAMINE (AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE (COMPLEXED WITH SODIUM POLYSTYRENE SULFONATE)) 5 MG | Marketed | |
| 02559811 | DYANAVEL XR | KYE PHARMACEUTICALS INC. | Tablet (Extended-Release) | Oral | AMPHETAMINE (AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE (COMPLEXED WITH SODIUM POLYSTYRENE SULFONATE)) 10 MG | Marketed | |
| 02559838 | DYANAVEL XR | KYE PHARMACEUTICALS INC. | Tablet (Extended-Release) | Oral | AMPHETAMINE (AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE (COMPLEXED WITH SODIUM POLYSTYRENE SULFONATE)) 15 MG | Marketed | |
| 02559846 | DYANAVEL XR | KYE PHARMACEUTICALS INC. | Tablet (Extended-Release) | Oral | AMPHETAMINE (AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE (COMPLEXED WITH SODIUM POLYSTYRENE SULFONATE)) 20 MG | Marketed |
Browse other molecules: